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ARGUMENT 
L MATRIX DID NOT WAIVE ANY ARGUMENTS BY CHOOSING NOT TO 
RAISE THEM IN ITS OPENING BRIEF, 
Innerlight's brief reads as though there had been a bench trial below. But on 
appeal from summary judgment, the reviewing court gives no deference to the trial 
court's legal conclusions or factual findings. The standard of review is de novo; this 
Court reviews the case anew. 
A. On Summary Judgment, A Trial Court Does Not Find Facts Or Resolve 
Factual Disputes. 
On appeal from summary judgment, this Court gives no weight or credence to the 
trial court's factual findings, since, "by definition, a district court does not resolve issues 
of fact at summary judgment. . . ." Poteet v. White, 2006 UT 63, \ 7, 147 P.3d 439, 441 
(Utah 2006); see also Ellsworth v. Am. Arbitration Ass % 2006 UT 77, % 19 n.10, 148 
P.3d 983, 989 n.10 (Utah 2006) (refusing to give deference to the trial court's findings of 
fact on appeal from a summary judgment ruling, then reiterating that on summary 
judgment, a trial court errs in finding facts because a trial court "should not resolve 
factual disputes"). 
Further, a reviewing appellate court affords "no . . . deference to the trial court's 
legal conclusions . . . . " Wycalls v. Guardian Title, 780 P.2d 821, 824 (Utah Ct. App. 
1989); see also Ron Shepherd Ins. v. Shields, 882 P.2d 650, 654 (Utah 1994) ("[W]e do. 
not defer to the trial court's rulings We determine only whether the trial court erred 
in applying the governing law and whether the trial court correctly held that there were 
not disputed issues of material fact.") (quotations and citation omitted). 
Therefore, since this Court reviews the trial court's decision "de novo, reciting all 
facts and fair inferences drawn from the record in the light most favorable to the 
nonmoving party," the reasoning and rationale behind the trial court's decision is 
irrelevant.1 Poteet, 2006 UT 63, f7, 147 P.3d at 441; see also 4 Am. Jur. 2d Appellate 
Review § 99 (2008) (uAn appeal cannot be taken from an instrument containing only the 
reasons for judgment, but must be taken from the judgment itself"). Matrix had no 
obligation to counter each basis for the trial court's decision to preserve any argument on 
appeal. 
B. Innerlight's Standard Is Tantamount To A Marshaling Requirement That Is 
Neither Necessary Nor Required. 
This Court expressly rejected a marshaling requirement for appellants when 
appealing from summary judgment: "[w]hen appealing a district court's grant of 
summary judgment... the appellant has no obligation to marshal the evidence." Smith v. 
Four Corners Mental Health Ctr., Inc., 2003 UT 23, Tf 16 n.6, 70 P.3d 904, 910 n.6 (Utah 
2003). Rather, "[t]he marshaling obligation only arises after a party challenges the 
sufficiency of the evidence to support a jury's verdict or a district court's ruling 
containing specific findings of fact." Id. And since, at the "summary judgment stage, the 
district court is not concerned about the sufficiency of any evidence" or findings of fact, 
the appellant need not marshal. Id. 
1
 Innerlight submitted a twenty-one page order, reciting findings of facts and 
conclusions of law. (R. at 857-77.) Matrix objected to the proposed order, arguing that 
"[s]ince the [trial court] disposed of [the] case on summary judgment, the appellate court 
[would] review[] the case de novo." (R. at 804-05.) The trial court overruled the 
objection and signed and entered Innerlight's proposed order. 
Innerlight's marshaling requirement is not necessary or required when appealing 
from a trial court's grant of summary judgment. Therefore, Matrix did not waive any 
arguments on appeal by electing not to address them in its opening brief. 
C. When The Trial Court Granted Summary Judgment For Innerlight The 
Court Vindicated Innerlight's Sole Cause Of Action. 
Innerlight began and ended this case with a thirteen-paragraph complaint and a 
single cause of action. It sought a declaratory judgment that "the parties have not entered 
into a valid contract. . . ." (R. at 16.) Innerlight then moved for summary judgment on 
that single cause of action. (R. at 134-217.) When the trial court granted summary 
judgment, it adjudicated Innerlight's single cause of action, declaring that no contract 
existed between Innerlight and Matrix. (R. at 857.) 
Each and every argument and theory that Innerlight proposed was not a separate 
claim or cause of action that Matrix had to address in its opening brief.2 On appeal, this 
Court reviews the record as a whole, giving no deference to the trial court or its factual or 
legal conclusions. The only issues are whether there is a disputed issue of material fact 
and whether the movant is entitled to judgment as a matter of law. 
Therefore, since the trial court granted summary judgment as to Innerlight's sole 
cause of action, Matrix did not have to address, in its opening brief, every justification for 
the trial court's decision to preserve Matrix's ability to counter those arguments on 
appeal once Innerlight raised them. 
IX Innerlight's Cases Do Not Support Its Conclusion. 
2
 Innerlight did not cite a single case for this proposition. 
Innerlight's five cited cases do not support its argument that on appeal, Matrix was 
obligated, in its opening brief, to address and counter each basis for the trial court's 
decision. 
1. Am. Towers v. CCI Mech., Inc., 930 P.2d 1182 (Utah 1996). 
First, Innerlight cited Am. Towers v. CCI Mech., Inc. for the proposition that 
"[ijssues not briefed by an appellant are deemed waived and abandoned." 930 P.2d 1182, 
1185 n.5 (Utah 1996). (Appellee's Br. 13.) In American Towers, the trial court 
dismissed some claims against the defendants because they were shareholders of entities 
that developed the real estate project at issue, and the court held the corporate veil could 
not be pierced. Id. at 1185. The appellant did not address or appeal the dismissal of 
these defendants, so this Court, in an attempt at clarity, dropped a footnote and held that 
since the appellant did not appeal or address the dismissal of these specific defendants, 
the issue was waived. Id. at 1185 n.5. This does not support Innerlight's argument that, 
after a trial court grants summary judgment, the appellant must counter, in its opening 
brief, each and every argument relied upon by the court. 
2. Coroles v. Sabey, 2003 UT App 339, 79 P.3d 974 (Utah Ct. App. 
2003). 
Innerlight cited Coroles v. Sabey for the proposition that an appellant must meet 
"minimum standards . . . to challenge a trial court's ruling and avoid abandoning any 
claim of error." 2003 UT App 339, 79 P.3d 974 (Utah Ct. App. 2003). (Appellee's Br. 
13.) Coroles is factually distinguishable. In Coroles, the plaintiffs/appellants brought 
thirteen causes of action, and the trial court dismissed the entire complaint. Id. at ^  6, 9, 
979. The plaintiff/appellant presumed to appeal the trial court's ruling with respect to 
each of the thirteen individual causes of action. Id. In its opening brief, the appellant 
titled section I of the brief "THE TRIAL COURT ERRED IN DISMISSING THE 
ENTIRE COMPLAINT." Id. In spite of this broad language, the appellant provided no 
analysis in the brief of five of the thirteen causes of action that were supposedly appealed. 
Id. On appeal, this Court held that the appellant's global reference alone did not 
constitute the analysis required to brief the five causes of action that the appellant all but 
ignored. Id. 
Contrary to Coroles, Matrix is not briefing only one of Innerlight's several causes 
of action. Rather, Innerlight had only one cause of action—a declaratory judgment that 
the parties did not execute the Exclusive Distributor Agreement ("Contract"). Innerlight 
moved for summary judgment on that single cause of action, and the trial court granted 
the motion. Matrix then appealed that ruling on Innerlight's single cause of action. 
3. Pasquin v. Pasquin, 1999 UT App 245, 988 P.2d 1 (Utah Ct. App. 
1999). 
Innerlight cited Pasquin v. Pasquin for the argument that an appellant "has waived 
any challenge to this ruling by failing to raise, brief, or argue the issue." 1999 UT App 
245, U 21, 988 P.2d 1, 6 (Utah Ct. App. 1999). (Appellee's Br. 13.) In Pasquin, the court 
issued an odd, separate "additional" ruling that the plaintiff could not recover under a 
specific cause of action. Id. The plaintiff did not appeal that issue, nor did she "raise, 
brief, or argue" it. Id. Therefore, the court of appeals declined to address it. 
In the instant case, Matrix followed the letter of the law and raised the only issue it 
could—the trial court's ruling on summary judgment which vindicated Innerlight's sole 
cause of action. And Innerlight can point to no case, rule, or statute that supports the 
marshaling that Innerlight argues for. 
4. Eddy v. Albertson % Inc., 2001 UT 88, 34 P.3d 781 (Utah 2001), 
and Coleman v. Stevens, 2000 UT 98,17 P.3d 1122 (Utah 2000). 
Innerlight cited Eddy v. Albertson's, Inc. and Coleman v. Stevens for the 
proposition that an appellate court "will not consider matters raised for the first time in 
the reply brief." Eddy, 2000 UT 98, f 21, 34 P.3d at 785 (citation and quotations 
omitted). (Appellee's Br. 15.) In Eddy, the plaintiff requested attorneys' fees—-for the 
first time in the entire case—in his appellate reply brief. Id. Clearly, since the trial court 
did not have an opportunity to address that issue below, the plaintiff had not preserved 
the issue for appeal, and the appellate court could not pass on the issue. Similarly, in 
Coleman, the appellant tried to raise issues for the first time on appeal that he did not 
raise in the trial court. Coleman, 2000 UT 98,1f9, 17 P.3d at 1124. 
Eddy and Coleman present different factual scenarios than the instant case. Both 
in the trial court and on appeal, Matrix opposed and contested the trial court's grant of 
Innerlight's summary judgment and denial of Matrix's summary judgment. (R. at 907-
09.) Therefore, Eddy and Coleman are distinguishable and do not apply. 
IL INNERLIGHT FULFILLED THE CONDITION PRECEDENT. 
The Contract, executed by the parties, in Section 2(b), did call for Innerlight—not 
Matrix—to take the affirmative step of accepting, in writing, the prices of the products it 
would purchase from Matrix.3 (R. at 455.) Section 2(b) did not require Innerlight's 
written acceptance to take a certain form or to include specific, "magic" language. 
Innerlight complied with the condition precedent when it sent six individual, 
official purchase orders to Matrix—each purchase order containing the "per unit" price of 
each item ordered—totaling more than $250,000 worth of Beverly Sassoon skin care 
products. (R. at 462-67.) (Copies of these six purchase orders are attached hereto as 
Addendum B.) Innerlight also took "acceptance" of the products' prices a step further by 
having one of its employees, Ms. Kathy Christensen, sign each purchase order (r. at 462-
67), something Section 2(b) did not require (r. at 455). These purchase orders constituted 
prima facie fulfillment of Section 2(b) of the Contract—acceptance, in writing, of the 
products' prices. 
Innerlight argues the legal proposition, without citation to any legal authority, that 
purchase orders "are insufficient as a matter of law to constitute an 'acceptance'" of the 
products' prices. (Appellee's Br. 21.) This is not a principle of law; rather, it is 
Innerlight's conclusory, self-serving interpretation of Section 2(b) of the Contract. 
Section 2(b) did not require Innerlight's "acceptance" to take a certain form or to contain 
specific language. It required only what it said and nothing more: written acceptance of 
the products' prices, and the purchase orders fulfill that requirement. 
And as Innerlight's own actions prove, Innerlight and Matrix did agree on the 
3
 Section 2(b) of the Contract states that "[t]he acceptance of this appointment by 
[Innerlight] is conditioned upon [Innerlight's] written acceptance of [Matrix's] Product 
Price List which shall not be subject to change until October 17, 2006" (emphasis added). 
(A copy of the Contract is attached hereto as Addendum A.) 
products5 pricing. (See Section II.A, pp. 19-23, in Appellant's opening brief.) These 
actions evidenced Innerlight's belief that it entered into a binding agreement by 
performing a laundry list of actions over the eighteen-month life of the Contract, all of 
which stemmed from the power granted Innerlight from the Contract.4 Curiously, when 
4
 These actions include Innerlight: (1) placing exclusive Beverly Sassoon skin care 
products on its website for more than a year and a half after the Contract was signed 
(through June 2006—months after Innerlight repudiated the Contract), including pictures 
of Beverly Sassoon and information touting the benefits of the products (r. at 678) 
(Addendum C); (2) publishing a pricelist of the Beverly Sassoon skin care products on its 
website (r. at 679); (3) generating several individual purchase orders, each with its own 
number, to purchase Beverly Sassoon products from Matrix (r. at 679) (Addendum B); 
(4) paying Matrix more than $250,000 for Beverly Sassoon products (r. at 679) 
(Addendum D); (5) exercising its option under Section 4 of the Contract by requiring 
Beverly Sassoon to appear in Las Vegas to promote Innerlight's exclusive, newly 
launched Beverly Sassoon skin care product line (r. at 679) (Addendum E); (6) paying 
Defendant $2500 for Sassoon's appearance in Las Vegas pursuant to Section 4 of the 
Contract (r. at 679) (Addendum E); (7) paying the travel costs and expenses, pursuant to 
Section 4 of the Contract, that were incurred from Sassoon's appearance in Las Vegas (r. 
at 679) (Addendum E); (8) exercising its option again under Section 4 of the Contract by 
requiring Beverly Sassoon to appear in Newark, New Jersey to promote Innerlight's 
exclusive Beverly Sassoon skin care product line (r. at 679) (Addendum F); (9) paying 
Matrix $2500 for Sassoon's appearance in Newark, New Jersey pursuant to Section 4 of 
the Contract (r. at 679) (Addendum F); (10) issuing press releases from Innerlight's 
parent company, The Quigley Corporation, stating that Innerlight had "exclusive" rights 
concerning Beverly Sassoon-brand skin care products and that Beverly Sassoon had 
become Innerlight's spokesperson (r. at 679) (Addendum G); (11) filing an 8K statement 
of its parent company, The Quigley Corporation, with the Securities and Exchange 
Commission announcing that The Quigley Corporation had launched an exclusive 
Beverly Sassoon skin care product line (r. at 679-80); and (12) filing a 10-Q statement of 
The Quigley Corporation with the Securities and Exchange Commission announcing that 
it had launched an exclusive skin care line under the Beverly Sassoon brand name (r. at 
680) (Addendum H). 
Also, for the Court's information, a form 8K is "the 'current report' companies 
must file with the SEC to announce major events that shareholders should know about." 
U.S. Securities and Exchange Commission, available at 
http://www.sec.gov/answers/fonTi8k.htm. And a form 10-Q is a quarterly report 
containing information that federal securities laws requires publicly traded companies to 
Matrix invoiced Innerlight for Beverly Sassoon's appearances in both Las Vegas and 
Newark, Matrix's description on the invoice stated "Beverly Sassoon Appearance Fee— 
Per Contract' (emphasis added). (R. at 514.) (Adds. E, F.) Matrix also billed Innerlight 
for Ms. Sassoon's hotel stay and her airfare. (R. at 514.) Innerlight paid the total due, 
$3548.30, on an Innerlight check, number 64868. (Copies of these documents are 
attached hereto as Addendum E.) 
Even if the Court were to fine that Innerlight purchase orders did not fulfill 
Section 2(b) of the Contract, Innerlight's laundry list of actions support Matrix's 
equitable arguments from its opening brief that: (1) Innerlight waived or excused the 
condition precedent (Appellant's Opening Br. 23-26); (2) Innerlight ratified the Contract 
by reaping its benefits for eighteen months (Appellant's Opening Br. 26-31); and (3) 
Innerlight is equitably estopped from denying the existence of the Contract and from 
being obligated to its terms and conditions (Appellant's Opening Br. 32-34). 
IIL INNERLIGHT'S UCC ARGUMENTS DO NOT PRECLUDE THE 
ENFORCEMENT OF THE CONTRACT'S FORUM SELECTION 
CLAUSE, 
Innerlight cited to the entire "sales" portion of the Uniform Commercial Code,5 
UCC 2-101 to 2-807, to support its argument that this Court should affirm the trial court's 
summary judgment rulings. (Appellee's Br. 14.) But for each of Innerlight's citations to 
disclose on an ongoing basis, such as unaudited financial statements. U.S. Securities and 
Exchange Commission, available at http://www.sec.gov/answers/formlOq.htm. 
5
 Utah adopted the Uniform Commercial Code and codified it in section 70A-1-
101 et seq. of the Utah Code. For convenience, throughout this brief, Matrix will refer to 
the UCC section (e.g., UCC 2-202(1)), which perfectly corresponds with the Utah Code 
section (e.g., Utah Code Ann. § 70A-2-202(l)). 
the UCC, there is an exception or a counter-provision that renders Innerlight's UCC 
arguments inert and that actually supports Matrix's arguments that the trial court erred in 
granting summary judgment to Innerlight and denying summary judgment to Matrix. 
A. The General Application Of The Uniform Commercial Code. 
The Uniform Commercial Code, which Utah wholesale adopted, "must be 
liberally construed and applied to promote its underlying purposes and policies . . . ." 
Utah Code Ann. § 70A-la-103(l). These include simplifying and clarifying the law of 
commercial transactions, expanding commercial practices "through custom usage, and 
agreement of the parties," and making commercial law more uniform among 
jurisdictions. Id. § 70A-la-103(l)(a) to (c). Additionally, principles of law and equity— 
including estoppel, ratification, and waiver—supplement the UCC.6 Id. § 70a-la-103(2). 
R UCC Section 2-204(1): Conduct By Both Parties That Recognizes The 
Existence Of A Contract Is Sufficient To Show Agreement. 
Overriding each and every UCC argument Innerlight makes is the principle that 
parties' conduct may recognize and prove the existence of a binding agreement in spite of 
the provisions of that agreement. Section 2-204(1) states that "[a] contract for sale of 
goods may be made in any manner sufficient to show agreement, including conduct by 
both parties which recognizes the existence of such a contract." Utah Code Ann. § 70A-
6
 The official comments to the UCC can also be very instructive in applying its 
principles. The Utah Court of Appeals has held that the comments to the UCC "are by 
far the most useful aids to interpretation and construction, promoting reasonably unifonn 
interpretation of the code by the courts." Power Sys. & Controls, Inc. v. Keith's Elec. 
Constr. Co., 765 P.2d 5, 11 n.3 (Utah Ct. App. 1988) (citation and quotations omitted). 
Therefore, where appropriate and instructive, Matrix cites to the UCC's Official 
Comments. 
2-204(1) (emphasis added). The Official Comment to this section clarifies and endorses 
this idea: "appropriate conduct by the parties may be sufficient to establish an 
agreement." 
In this case, the parties' conduct—particularly Innerlight's twelve discrete actions 
described in footnote 4 supra—evidence their recognition and endorsement of the 
Contract. Innerlight performed under the Contract for eighteen months and reaped the 
benefits of the Contract for that duration. Innerlight issued press releases (Add. G), made 
SEC filings (Adds. H, I), advertised and sold the products (Adds. C, D), and even secured 
and paid for Beverly Sassoon to appear—twice—to promote the products (Adds. E, F). 
Innerlight could not have done any of these acts without the Contract. 
Section 2-204(1) allows parties' conduct to evidence their recognition of an 
agreement for the sale of goods. Innerlight's and Matrix's conduct for a year and a half 
evidenced their understanding, belief, and intent that the Contract was in effect. 
C. UCC Section 2-305(4): The Parties Fixed The Products' Prices. 
Throughout its brief, Innerlight makes sporadic reference to UCC section 2-305(4) 
as justification for the trial court finding that no contract existed. (Appellee's Br. 7, 15, 
16, 24, 29.) In relevant part, section 2-305(4) provides that where "parties intend not to 
be bound unless the price be fixed or agreed and it is not fixed or agreed there is no 
contract." Utah Code Ann. § 70A-2-305(4). 
The syllogism, Matrix assumes, goes like this: (1) based on Section 2(b) of the 
Contract, Matrix and Innerlight did not intend to be bound unless the products' prices 
were fixed; (2) Matrix and Innerlight never fixed the prices; therefore (3) there is no 
contract. 
The flaw in InnerHght's argument lies in point number two. Contrary to 
Innerlight's unfounded claim, the parties actually fixed the prices when the principals of 
Matrix and Innerlight negotiated and decided upon the products' prices (discussed in 
Section II.A, p. 20, in Appellant's Opening Brief), which is evidenced by Innerlight's 
several purchase orders containing the per unit prices of each product. (R. at 462-67.) 
These per unit prices were the same prices that Matrix and Innerlight fixed before signing 
the Contract. (R. at 676.) Therefore, UCC 2-305(4) is not a bar to enforcing the forum 
selection clause in the Contract. 
a UCC Section 2-202(1): InnerHght's Purchase Orders Are Not "Evidence Of 
Any Prior Agreement Or Of A Contemporaneous Oral Agreement." 
Next, Innerlight argues that UCC section 2-202(1) precludes Matrix from using 
InnerHght's purchase orders as evidence that the parties fixed the products' prices 
because the prices in the purchase orders, Innerlight argues, contradict the terms of the 
Contract. (Appellee's Br. 20.) But section 2-202(1), by its own terms, applies only if a 
party tries to use a prior or contemporaneous agreement to alter the terms of an original 
agreement, which Matrix is not doing here. Section 2(b) of the Contract called for 
Innerlight, via documentation other than the Contract itself, to accept, in writing, the 
products' prices, which Innerlight did through its several purchase orders listing the per 
unit price for each item. Thus, Innerlight did exactly what Section 2(b) of the Contract 
Innerlight implies that Section 2(b) of the Contract required Matrix to submit a 
company price list before Innerlight could provide written acceptance of the products' 
prices. (Appellee's Br. 26 n.9.) But this alleged requirement is fictional. Section 2(b) 
demanded. 
Section 2-202(1) states, in relevant part: 
Terms with respect to which the confirmatory memoranda of the 
parties agree or which are otherwise set forth in a writing intended 
by the parties as a final expression of their agreement with respect to 
such terms as are included therein may not be contradicted by 
evidence of any prior agreement or of a contemporaneous oral 
agreement.... 
In this case, Matrix is not attempting to contradict the terms of the Contract by 
looking to Innerlight's purchase orders as evidence of Matrix and Innerlight fixing the 
prices. Rather, Section 2(b) specifically mandated Innerlight to accept, in writing, the 
products' prices, and Innerlight had to do that via documentation other than the Contract 
itself. It is impossible not to refer to some other documentation as evidence that 
Innerlight fulfilled Section 2(b), and in this case, we look to Innerlight's purchase orders. 
Moreover, Innerlight's argument does not work because its purchase orders do not 
contradict any provision in the Contract. In fact, the Contract specifically required the 
parties to look to some other documentation as evidence of the products' prices. 
Innerlight's argument would apply only if the Contract itself recited the products' prices, 
and Matrix then tried to use Innerlight's purchase orders to contradict the prices 
established in the Contract. But that is not the case. 
Additionally, even if section 2-202 applied to bar Matrix's reference to 
Innerlight's purchase orders as fulfillment of Section 2(b) of the Contract, subsections (1) 
and (2) of section 2-202 provide exceptions to the rule by allowing the parties' course of 
puts the onus on Innerlight, not Matrix, to accept the products' prices, which Innerlight 
did via its purchase orders. 
performance, and consistent additional terms, to supplement and explain the Contract. 
1. Section 2-202(1) allows the parties5 "course of performance55 to 
supplement and explain the terms of the Contract. 
Contrary to Innerlight's assertions, subsection (1) of 2-202 allows parties' "course 
of performance" to explain or supplement a contract. In this case, that means Innerlight's 
purchase orders, as well as Innerlight reaping the benefits of the Contract for a year and a 
half, evidenced that Innerlight accepted the products' prices. 
Subsection (1) of 2-202 states that terms of a contract "may not be contradicted by 
evidence of any prior agreement or of a contemporaneous oral agreement but may be 
explained or supplemented . . . by course of performance (Section 70a-2-208) . . . ." Utah 
Code Ann. § 70A-2-202 (emphases added). 
The "course of performance" statute referred to above, section 70A-2-208, 
o 
establishes what "course of performance" means and how it operates. Subsection (1) of 
2-208 states that 
[wjhere the contract for sale involves repeated occasions for performance 
by either party with knowledge of the nature of the performance and 
opportunity for objection to it by the other, any course of performance 
accepted or acquiesced in without objection shall be relevant to determine 
the meaning of the agreement. 
The next subsection of 2-208, subsection (2), provides that the express terms of the 
Section 2-208, the "course of performance" exception, is also known as the "rule 
of practical construction." Utah Code Ann. § 70A-2-208. This rule "is predicated on the 
common sense concept that actions speak louder than words," and this Court adopted the 
rule in 1965 with Bullough v. Sims, 400 P.2d 20, 23 (Utah 1965) (citations and quotations 
omitted). The Restatement of Contracts, section 235, defines the Rule as follows: "If the 
conduct of the parties subsequent to a manifestation of intention indicates that all of the 
parties placed a particular interpretation upon it, that meaning is adopted if a reasonable 
person could attach it to the manifestation." 
agreement and any course of performance "shall be construed whenever reasonable as 
consistent with each other " Utah Code Ann. § 70A-2-208(2). 
Taken together, then, 2-208(1) and (2) establish an exception to 2-202 which 
generally does not allow the parties' conduct to alter or explain their agreement. The 2-
208 exception looks to the parties' course of performance to explain and clarify the 
meaning of the parties' agreement, so long as the agreement calls for repeated occasions 
for performance. And any course of performance must be construed as consistent with 
the terms of the agreement. 
The Contract between Innerlight and Matrix involved repeated occasions for 
performance, which, in this case was not limited to Innerlight issuing six separate 
purchase orders for more than $250,000 worth of Matrix's products. In addition to the 
purchase orders, Innerlight also performed under the Contract for eighteen months in 
numerous and varied ways by, inter alia, twice procuring Beverly Sassoon to appear and 
promote Innerlight's products (r. at 679), advertising and selling the products on its 
website (r. at 678-79), issuing multiple press releases about the Contract (r. at 678-80), 
and making SEC filings based on its Contract with Matrix (r. at 679-80). 
Construing Innerlight's performance as consistent with Section 2(b) of the 
Contract (as 2-208(2) requires), it becomes evident that Innerlight intended to accept— 
and in fact did accept—the products' prices. 
2. Section 2-202(2) allows the Court to consider Innerlight's 
purchase orders as "consistent additional terms" with the 
Contract. 
Subsection (2) of 2-202 provides another exception, besides the "course of 
performance" exception, that operates to "explain[] or supplement^' the terms of a 
contract. Subsection (2) says that terms of a contract may be explained or supplemented 
by evidence of consistent additional terms, provided the agreement is not a complete 
statement of the terms of the agreement. In this case, the Contract is not an exclusive and 
complete statement of the terms between Innerlight and Matrix because Section 2(b) 
demanded that Innerlight accept the products' prices in a separate document. Therefore, 
the per unit prices in Innerlight5s purchase orders fall under subsection (2) and may 
explain or supplement the terms of the Contract, specifically, Section 2(b). 
Subsection (2) of 2-202 states, in relevant part, that terms of a contract 
may not be contradicted by evidence of any prior agreement or of a 
contemporaneous oral agreement but may be explained or supplemented: 
. . . (2) by evidence of consistent additional terms unless the court finds the 
writing to have been intended also as a complete and exclusive statement of 
the terms of the agreement. 
In this case, Innerlight5s purchase orders fall squarely within the definition of 
"consistent additional terms" because Section 2(b) requires Innerlight to accept the 
products' prices via documentation other than the Contract. The several purchase orders 
constitute the documentation required by Section 2(b), and moreover, they are consistent 
with the terms of the Contract. Therefore, the Court should read the purchase orders as 
explaining and supplementing the Contract, specifically, Section 2(b). 
Innerlight may argue that the Court should not allow the purchase orders to 
explain or supplement the Contract as "consistent additional terms" because the Contract 
is "a complete and exclusive statement of the terms of the agreement." But Section 2(b) 
belies that argument. That section explicitly requires the parties to look to some other 
documentation, some other evidence, that Innerlight agreed to the products' prices. 
Therefore, the Contract was not the "complete and exclusive" statement of the parties' 
agreement—the price term, an integral part of any contract, was omitted, and the Contract 
specifically directed the parties to some other documentation for evidence of the 
products' prices. 
Therefore, this Court should look to Innerlight's purchase orders as evidence of 
consistent additional terms to explain and supplement the Contract. 
K UCC Section 2-208(3): The Parties' "Course Of Performance" Can Show 
Waiver Or Modification Of Any Term In The Contract, Including Section 
2(b) And The Anti-waiver Clause. 
Innerlight argues that it did not waive the condition precedent in Section 2(b) or 
the anti-waiver clause in Section 12 of the Contract. (Appellee's Br. 10, 28-34.) But 
section 2-208(3) states that course of performance is "relevant to show a waiver or 
modification of any term inconsistent with such course of performance."10 
A waiver is "the intentional relinquishment of a known right." Soter's, Inc. v. 
Deseret Fed. Sav. & Loan Ass % 857 P.2d 935, 940 (Utah 1993) (citation and quotation 
omitted). There are three elements to show waiver: "(1) an existing right, benefit, or 
advantage; (2) knowledge of its existence; and (3) an intention to relinquish the right." 
Id. A waiver must be distinctly made, though it may be express or implied. Id. 
9
 Official Comment 1 to UCC 2-201 explains that "[i]n many valid contracts for 
sale the parties do not mention the price in express t e rms . . . . [Frequently the prices is 
not mentioned since the parties have based their agreement on a price list or catalogue 
known to both of them and this list serves as an efficient safeguard against perjury." 
10
 The Official Comment to the UCC also adds that "[u]nder this section a course 
of performance is always relevant to determine the meaning of the agreement" (emphasis 
added). 
Innerlight met each of these elements and either expressly or impliedly waived the 
condition precedent and the anti-waiver clause. 
First, Innerlight waived the condition precedent, and all three elements for waiver 
are met: (1) Section 2(b) of the Contract was a right, benefit, or advantage for Innerlight; 
(2) Innerlight knew about Section 2(b) of the Contract (Section 12 of the Contract also 
states each party had the assistance of counsel in reviewing and signing the Contract); 
and (3) Innerlight's twelve discrete, undisputed actions make clear that Innerlight 
intended to relinquish the right in Section 2(b) and the anti-waiver provision in Section 
12 because Innerlight performed under the Contract for a year and a half.11 
Second, Innerlight also waived the anti-waiver clause in Section 12 of the Contract 
by continuing to perform under the Contract for eighteen months (r. at 459). Although 
initially counterintuitive, for more than sixty years, this Court's jurisprudence has held 
that a party may waive an anti-waiver clause. Living Scriptures, Inc. v. Kudlik, 890 P.2d 
7, 10 n.3 (Utah Ct. App. 1995) (citing, inter alia, Calhoun v. Universal Credit Co., 146 
P.2d 284, 286 (Utah 1944)) ("[CJourts have concluded that [nonwaiver provisions] may 
be waived."); see also 1 White and Summers, Uniform Commercial Code, 4th Ed. §§ 1-6, 
p.41-42 (u[P]arties may . . . provide that no waiver shall bind unless in writing. This 
clause itself may be waived .. ."). More recently, in State v. Pena, this Court 
acknowledged that over time, it had "developed hopelessly inconsistent elaborations on 
1 ]
 Moreover, an anti-waiver clause in a contract does not, by itself, prevent a party 
from waiving any provision in the contract. Living Scriptures, Inc. v. Kudlik, 890 P.2d 7, 
10 n.3 (Utah Ct. App. 1995) (concluding that "the best approach is to view the existence 
of an anti-waiver provision as merely one factor to consider in determining whether a 
party has waived its right under the agreement"). 
the basic statement of waiver principles." 869 P.2d 932, 938 (Utah 1994) (citation 
omitted) (referring to both civil and criminal examples). In light of the confusion, the 
Court "stripped the statement of the law back to its most basic form and told the trial 
courts to apply it." Id. (citation omitted). 
Therefore, whether Innerlight waived the anti-waiver clause in Section 12 is 
analytically no different than the question of whether Innerlight waived any other 
provision of the Contract. Rather, the question of waiver of any clause "is a highly fact-
dependent question" that must be determined ad hoc. Pena, 869 P.2d at 938. 
Innerlight's course of performance, and its exercise of rights that stemmed only 
from the Contract, were so pervasive that one must conclude that Innerlight explicitly or 
implicitly waived both Section 2(b) and the anti-waiver clause in Section 12. 
R UCC Section 2-209(5): Innerlight Failed To Timely Rescind Its Waiver. 
Innerlight next argues that even if it did waive Section 2(b) and the anti-waiver 
provision, it timely rescinded the waivers under section 2-209(5). (Appellee's Br. 10, 
29.) But Innerlight's alleged rescission was not timely, reasonable, or just. Further, 
Innerlight failed to comply with the terms of 2-209(5), which required Innerlight to 
provide reasonable notification to Matrix that Innerlight would expect strict compliance 
with the Contract. 
Section 2-209(5) allows a party to retract a waiver, but only if the retracting party 
meets certain conditions: 
[a] party who has made a waiver affecting an executory portion of the 
contract may retract the waiver by reasonable notification received by the 
other party that strict performance will be required of any term waived, 
unless the retraction would be unjust in view of a material change of 
position in reliance on the waiver. 
To comply with section 2-209(5), Innerlight had to (1) provide reasonable 
notification to Matrix, (2) ensure that Matrix received the notification, and (3) convey 
that strict performance would be required of the waived terms (Section 2(b) and the anti-
waiver clause). 
After reaping the benefits of the Contract for eighteen months, Innerlight notified 
Matrix that Innerlight deemed the Contract invalid and that Innerlight would no longer be 
selling Beverly Sassoon products. (R. at 528, 534.) Innerlight failed to convey, however, 
that strict performance with Section 2(b) and the anti-waiver provision would be 
required, which section 2-209(5) demands. Rather, Innerlight merely stated that "it is 
[Innerlight's] belief that the Contract was never accepted." (R. at 528.) 
Moreover, even if Innerlight met the three requirements in 2-209(5), which it did 
not, that section precludes retraction if it would be unjust in view of a material change of 
position in reliance on the waivers. In this case, retraction would be unjust because 
Matrix materially changed its position in reliance on Innerlight's waivers of Section 2(b) 
and the anti-waiver clause. Most notably, Matrix forwent offering the exclusive 
distributorship to another entity. The Contract's recitals state that Innerlight "desires to 
be the exclusive distributor of certain of [Matrix's] BEVERLY SASSOON brand name 
products. . . and [Matrix] is willing to make [Innerlight] its exclusive distributor for such 
purposes. . .." (R. at 454.) The exclusive distributorship would have gone to another 
entity but for Innerlight signing the Contract (r. at 460) and acting pursuant to it for a year 
and a half. Matrix could have only one exclusive distributor. Innerlight acted as if it 
was, so Matrix was powerless to change this. 
IV. THE TRIAL COURT INCORRECTLY RULED ON THE PARTIES9 
MOTIONS TO STRIKE EACH OTHER'S AFFIDAVITS. 
A. Tate's Affidavit Contains Inadmissible Hearsay, So The Trial Court Should 
Have Stricken The Offending Paragraph. 
Paragraph thirteen of Wesley Tate's Affidavit (r. at 171-73) contains inadmissible 
hearsay. This Court should reverse the trial court and strike the offending paragraph. (A 
copy of the trial court's order, r. at 878-79, is attached hereto as Addendum I.) 
Rule 801(c) of the Utah Rules of Evidence defines hearsay as "a statement, other 
than one made by the declarant while testifying at the trial or hearing, offered in evidence 
to prove the truth of the matter asserted." Rule 802 goes on to exclude hearsay evidence 
except as provided by the rules of evidence. 
Paragraph thirteen of Tate's affidavit states: "Following the sale of certain 
Sassoon products purchased from Matrix, Innerlight received complaints from customers 
including, [sic] that a facial product caused 'burning' to the customer's skin, that a lotion 
was 'runny,' and that lotion pumps were inoperable." (R. at 191.) 
These statements are out-of-court statements offered for their truth, i.e., that 
Innerlight received complaints that the Beverly Sassoon skin care products caused 
"burning" or were "runny." Innerlight does not contest this—it admitted that Tate made 
these statements to show that "Innerlight had 'received complaints'" about the products. 
(Appellee's Br. 40.) Therefore, the statement is hearsay, no exception applies, and the 
Court should exclude it under Rule 802 of the Utah Rules of Evidence. 
B. The Trial Court Erred In Striking Catinella's Third Affidavit. 
1. Matrix opposed Innerlight's Motion to Strike. 
Innerlight argues Matrix "did not oppose [Innerlight's Motion to Strike]," and that 
Matrix filed "an untimely opposition to Innerlight's motion the day after the motion was 
decided," and therefore, the trial court was correct to grant Innerlight's motion to strike. 
(Appellee's Br. 40.) This is both misleading and incorrect. 
In late 2006, Matrix and Innerlight both filed motions for summary judgment and 
the accompanying affidavits. On September 29, 2006, Matrix filed its Motion to Strike 
Portions of Tate's Affidavit (which Innerlight had filed in support of its Motion for 
Summary Judgment). (R. at 411-17.) Then, on November 28, 2006, the trial court filed a 
Notice of Oral Argument. (R. at 735-37.) (A copy of this Notice is attached hereto as 
Addendum J.) The Notice stated that the Court would hear argument on January 17, 
2007 on three (and only three) motions: (1) Innerlight's Motion for Summary Judgment; 
(2) Matrix's Motion for Summary Judgment; and (3) Matrix's Motion to Strike Portions 
of Tate's Affidavit. (R. at 735.) (Add. J.) 
On January 4, 2007—two weeks before oral argument on the three motions above 
and a month and a half after the court sent the notice or oral argument—Innerlight filed 
its Motion to Strike Portions of the Third Affidavit of Anthony R. Catinella. (R. at 741-
43, 758-63.) Under Rule 6(a) (ten filing days excludes weekends) and Rule 7(c)(1) (must 
file an opposition to a motion within ten days) of the Utah Rules of Civil Procedure, 
Matrix had at least until January 18, 2007 to file its opposition. And Matrix filed its 
opposition on January 16, 2007 . (R. at 779.) 
Innerlight's motion to strike was never noticed for argument during the January 
hearing. Further, even if Innerlight's motion to strike had been noticed for argument at 
the January 17 hearing, Matrix could not submit Innerlight's motion for decision because 
the briefing time had not expired under Rule 7(c)(1). And even if the parties stipulated to 
jointly submit Innerlight's motion to strike at the hearing (in spite of the above defects), 
the trial court incorrectly concluded that Matrix's opposition was untimely filed, since 
Matrix filed its opposition on January 16, the day before the hearing. (R. at 779.) 
2. Matrix timely filed Catinella's third affidavit in conjunction 
with Matrix's reply memorandum in support of summary 
judgment 
Innerlight argues that the trial court properly struck Catinella's third affidavit (r. at 
703-20) "because it was untimely." (Appellee's Br. 41.) But Rule 56(e), which 
specifically speaks to the use of affidavits with summary judgment motions, states that 
"[t]he court may permit affidavits to be supplemented or opposed by . . . further 
affidavits." Indeed, it is the responsibility of each party, when moving for and opposing 
summary judgment, to submit affidavits so that the trial court may determine if there 
exists a genuine issue of material fact that would preclude granting the motion. Utah R. 
Civ. P. 56(c). There is no rule or case law that renders an affidavit filed with a reply 
memorandum "untimely." 
Innerlight cites Sunridge Dev. Corp, v. RB&G Eng'g, Inc., 2008 UT App 29, f9 
12
 Rule 5(b)(1)(B) of the Utah Rules of Civil Procedure states that "[s]ervice by 
mail . . . is complete upon sending." 
n.4, 177 P.3d 644, 647 n.4 (Utah Ct. App. 2008), for the proposition that an untimely 
affidavit is "subject to exclusion ceven if the results lead to a grant of summary judgment 
against the party seeking its introduction.5" (Appellee's Br. 41) (quoting Sunridge Dev., 
2008 UT App 29, | 9 n.4, 177 P.3d at 647 n.4). But that case is inapposite. There, the 
plaintiffs/appellants failed to timely submit a damages affidavit. Sunridge, 2008 UT App 
29, f9, 177 P.3d at 646-47. In this case, Matrix submitted an additional affidavit in 
support of its Motion for Summary Judgment with its reply memorandum. There is no 
rule or prohibition against such a submission or that makes the affidavit "untimely." 
3. Catinella's third affidavit complies with Rule 56(e), is based on 
personal knowledge, and contains no hearsay. 
Finally, Innerlight argues that paragraphs 3 and 8-14 of Catinella's third affidavit 
should be excluded because they are not based on personal knowledge and they are 
conclusory. (Appellee's Br. 41-45.) Each of Catinella's statements in these paragraphs is 
based on his personal knowledge and understanding of the history of events in this case. 
Admittedly, Catinella's recollection and understanding of this history may differ from 
Innerlight's recollection and affidavits, but that merely justifies the court in denying 
summary judgment, not in striking the affidavit. 
For example, Innerlight argues that Catinella's statement that the parties "agreed 
upon the prices at which [Innerlight] would sell" the products is a legal conclusion. 
(Appellee's Br. 42.) With this statement, Catinella merely recites his lay understanding 
of his negotiations and conversations with the principals of Innerlight. Nothing in his 
statement purports to convey what Innerlight or its principles believed or a legal 
•J o 
conclusion. 
V. PURSUANT TO RULE 24(a)(9), MATRIX REQUESTS ATTORNEYS9 
FEES AND COSTS ON APPEAL BASED ON SECTION 12 OF THE 
CONTRACT. 
Rule 24(a)(9) of the Utah Rules of Appellate Procedure requires that "[a] party 
seeking to recover attorney's fees on appeal shall state the request explicitly and set forth 
the legal basis for such an award." Pursuant to that rule, Matrix hereby explicitly 
requests attorneys' fees and costs on appeal based on Section 12 of the Contract14 and 
based on Utah law that allows for attorneys' fees when provided for in a contract. 
Stewart v. Utah Pub. Serv. Comm 7i, 885 P.2d 759, 782 (Utah 1994) ("[Attorney fees 
cannot be recovered unless authorized by statute or contract."). 
CONCLUSION 
Innerlight cannot revise history to disown its clear belief and intent to abide by the 
Contract after abiding by its terms for eighteen months, all while reaping the Contract's 
benefits. This Court should reverse the trial court and grant summary judgment for 
Matrix, thereby enforcing the forum selection clause and sending the parties to Florida to 
litigate. In the alternative, based on many disputed issues of material facts, and viewing 
the facts in a light most favorable to Matrix, the Court should reverse the grant of 
summary judgment for Innerlight and remand to the trial court. 
13
 Without reciting each of the eight disputed paragraphs and independently 
analyzing each paragraph, the argument above applies to each of the disputed paragraphs. 
Catinella repeatedly recites precisely what the Contract stated (r. at 703-07, ffl[ 3, 12) and 
the factual history of the parties' discussions and negotiations (r. at 705, ^  8-14). 
14
 Section 12 of the Contract allows the prevailing party in litigation concerning 
the Contract to received attorneys' fees and costs, including for "any and all appeals 
. . . . " (R. at 459.) 
RESPECTFULLY SUBMITTED this 7th day of May 2008. 
HILL, JOHNSON & SCHMUTZ, L.C. 
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EXCLUSrVE DIETRfftUTOn AGREEMENT 
THIS EXCLUSrVE DISTRIBUTOR AGREEMENT is made rind entered into as of* the 
day of . 2004. between THE MATRIX GROUP, LLC ("Company"), 
and INNERLIGHT, INC. ("Distributor11). 
W I T N E S S E T H 
WHEREAS, Company is licensed to sell products under the brand name "BEVERLY 
SASSOOK'11 ihroughoui ihc world; and 
WHEREAS, Distributor desires to be the exclusive distributor of certain of Company's 
BEVERLY SASSOOK brand name products in the multi-level marketing/network marketing 
industry within (he territory morc particularly described below, and Company'is willing to make 
Distributor iLs exclusive distributor for such purposes, all in accordance with and pursuant in (he 
terms and conditions more fully scl forth below; 
NOW, THEREFORE, in consideration of Lhe above, the mutual covenants and agreements 
sd forth herein, and other good and valuable consideration, ihc receipt and sufficiency of which are 
hereby acknowledged, ihc parties hereto do hereby agree 85 follows; 
1, Company Rcprcssntoiionsand Warranties. 
The Company hereby represents and warrants lo Distributor as follows; 
(a) ThBl Lhe Company: 
(i) has a license lo utilize (he BEVERLY SASSOON name on, among 
olhcr things, ihc Company's cosmetics, cosmasculjculs, nutrasculicsls, canning, 
make-up, vhamins, bahy-products ond pet products; and 
(ii) such license h for n slated-term at least as long as the term of this 
Agreement; and 
(ii/) the aforesaid license is in full force and cflfcel and Company is nol in 
default thereunder;'and 
(iv) Company will keep said license in effect for the full term of this 
Agreement; and 
(b) That in connection with the License A&rccmcnl for the BEVERLY 
SASSOON name with Bc\>cr)y Saloon International, LLC ("Licensor"), lhe Licensor has 
warranted thai it has rhc rights lo the BEVERLY 5ASSOON name and thai it wjlJ indemnify 
Company frnm nil los.icn. claims, damages, owards, penalties and injuries which may nri3c in 
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conncciion with any claim by ii/ty ihf rd parly of any Alleged infringement ofcypyri^hl, Iradcm/irk or 
other intellectual property rights pertaining (o the use nft/ie BEV'EftLY SASSOON niunc; and 
(c) Thut in fhe event /iny party makes any claim for Ihc infringement of 
copyright, trudcrn/irk or ofher inlcllecluul properly rights concerning (he use of ihc BEVERLY 
SASSOON brand name in connection with any of (he Producis (as defined below), Company will, 
promptly following its receipt of notice of such claim from Distributor, cidl upon Licensor (o 
provide (he indemnifications net/ui red under (he License Agreement between. Ihc Company and ihc 
Licensor and thai Com/winy will hold Distributor harmless from all losses, claims, damages, awards, 
penal lies or injuries arising ou( of such infringement claims. 
2. Appointment ofDislribulor. 
(H) Subjccl to the term* nod provisions sti forth in this Agreement, Company 
hereby appoints Distributor as the exclusive distributor for the Products (defined below) within the 
Territory (defined below) insofar 05, but only insofar as, Lhe Industry (defined below) is concerned, 
As used herein, ihc term "rYodacts" she!! mean the Company's cosmetics, cosmascuticals, 
niitrasfuricals, tanning, make-up, vitamins, baby-products and pet products from time 10 time 
bearing the BEVERLY SASSOON ruunt. As used herein, (he term "Territory" shall include aJI 
worldwide markets, including the United Stales, except for Asia (Asio is expressly excluded from 
Ihc Territor)'). .As .used herein, the term "Industry1' shall mean the multi-level marketing and 
network marketing; industries. Company expressly agrees that it will not sell Product5 bearing (he 
BEVERLY SASSOON name -within the Territory to any other party operating within Ihc Indusiry 
and that Company wiJI not itself-engage in (he Industry 10 sell 'Products bearing the BEVERLY 
SASSOON name on a multi-level marketing/network marketing basis. It is cxprcss)y understood 
and agreed, however, not by way of limitation, thai the Company-may sell BEVERLY SASSOON 
branded -prodacts or-services other than ihc'Products ID any other parties of its choosing, and thai 
Company may sell Producis bcarintJ the BEVERLY SASSOON name in any other parties of its 
choaring who are not involved in the Industry, in any market (world wide, regional,, local or other), 
•whether on a retail, wholesale or any other basis, and that Company may sell Products bearing the 
BEVERLY SASSOON name to companies engaged in the -Industry within the continent or Asia, alt 
without being in violation of this Agr&cmcnl. 
(b) The acceptance of (his appointment by Distributor is conditioned upon 
Distributor's v\Titte/) acceptance of Company's 'Product Price List which shall not be subject to 
change until October I 7, '2006. 
J. Term, 
Subject to ihc termination rights elsewhere set forth in this Agreement, the term of this 
Agreement shall commence as of the dnte first set forth above md shall end nn October 17, 2013, 
A.II obligations of the Company and all rights of Distributor shall ccaj;c and terminate ot the end of 
the aforesaid term and die Company shall thereafter be under no restrictions insofar as the sole of 
Products is concerned. 
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(ii) notwithstanding lhc rorc^omg, Distributor must purchase an amount of 
Products from Campuny each qunricf year period (i.e., uuch October 1 fl through ench 
January 17, and each January IS through each April 17, m\d each April IX through July 17, 
und each July IX through October 17 during each of .inch yean) equal to one-quarter of the 
Minimum Purchase Requirement Amount applicable to the yaw in question, with payment 
to be received by Company prior to (he end of each such applicable quarter 
6, Ltrriiuumns and Prohibitions on Distributor, 
It is understood *nd agreed thai 
(a) Distributor shall not have or Acquire nny rights to any patents, trademarks, 
serYiccrruirks, trade sccmls or nny olhcr intellectual properly rinhts relating in any manner to any of 
the Products or in or to the name of BEVERLY SASSOON. 
(b) Distributor shall have no rights to use the name BEVERLY SASSOON on 
any product olhcr Jhan Lhc Products. It is cxpirs^Jy understood and agreed that Distributor has no 
rights to use the name BEVERLY SASSOON on "Human Hair Care" relBlcd products as such 
•would violate the terms of Company's license with Licensor. 
(c) Distributor shall make no claims of health benefits, other benefits, or results 
customers could anticipate receiving from BEVERLY SASSOON Products unless such claims arc 
•expressly authorized in writing by Company or are contained on labels or other sales materials 
•provided by Company. Distributor shall no! make any claims concerning the Products, or 
concerning the BEVERLY SASSOON name, or concerning Beverly Sassoon the. person without 
first receiving the prior written authorization to do so From Company which approval may bc.givcn 
or withheld within the sole discretion of Company. 
(d) Distributor shall no( repackage any Product, remove art)' label or other 
identifying marking from any Product, or otherwise alter any packaging or label of any Product al 
any time. Distributor shall -not tamper whh< alter, modify, change or otherwise afTect any Produce 
sold to il by Company, 
(e) Distributor shall no! sell, produce, manufacture or otherwise be involved in or 
with respect to any goods or products similar (o or in competition in any way with any of the 
Products during the term of this Agreement. 
(F) Distributor shall comply wj(h oil Inwss stiihiics, rain and regulations of any 
and all governmental authorises having jurisdiction over its business opcrnt ions. 
(£.) Distributor 'ihtill market and act I the Products, and authorize her distributors 
to market and sell the Products, only within the Industry and only within the Territory. Neither 
Distributor nor any party acquiring (he Products through Distributor shall sell Lhc Products olhcr 
than rh rough the multi-level marketing/network marketing channels. 
u 1 I l: Ub U / : J u a /^ a T T f f 
7, Disclaimers, 
Except as expressly scl forth herein, Company makes no representations or warrantic;, to 
Distributor, cither ex-press or implied. SPECIFICALLY, BUT NOT 8Y WAY OF LIMITATION, 
COMPANY DISCLAIMS ALL WARRANTIES OF MERCHANTABILITY AND/OR FITNESS 
FOR. A PARTICULAR PURPOSE (N RESPECT OF THE PRODUCTS 
R. Default, 
(n) The occurrence at-any of Lhc following cvcnLs shall constitute an Even! of 
Default by Distributor under this Agreement: 
(l) Distributor sruJI fail ID sntisfy any Minimum Purchase Requirement it 
is obligated lo comply with pursuant to the provisions of (his Agreement or 
Distributor shall otherwise fail lopBy to Company any amount which Distributor is 
obligated to pay Lo Company; 
(ii) Distributor shall brach or fail to perform any other duty, obligation 
oragrccmcnl on Distributor's pnri to be complied with or performed pursuant to this 
Agreement and Distributor shall have failed to satisfy or curt such default within ten 
(10) days after the giving of written notice of such default lo Distributor by 
Company; or 
(lit) Distributor shall be or become the subject of any bankruptcy or 
insolvency proceedings. 
(b) Upon the occurrence of-any Event of Default, Company may exercise any 
one or more of Ihc following rights and remedies, afl of which shall be mutual and cumulativc.and 
no! exclusive: 
(i) Terminate this Agreement by giving written notice or such 
termination to Distributor; And/or 
(ii) Have and recover from Distributor all damages suffered by Company 
by reason of the occurrence ofsuch Even! of Default together with all reasonable attorneys 
fees and disburseTncnts expended or mcurml by Company in enforcing or pursuing lis rights 
under this Agreement; and/or 
(iii) Pursue any other rights or remedies tiYuilqbk to the Company a( law 
or in equity. 
9, Relation.ship, 
Nothing contained in ihis Agreement shall be construed as constituting a joint 
venture^ partnership, employer/employee rctntionship, franchise DJ other a^ocialjon between the 
parties hereto. Distributor is acting only in the capacity of an indcpcndcni contractor a n d shall hxtvc 
^C cr*. 
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no authority, express or implied, lo hind, oblijLjnjc or make any commitment or representation for of 
on behalf of Company. 
10. Notices, 
Any notice required or permitted lo be p.i^ cn by any party Lo the other under (liia Agreement shall be 
in writing and sha/l be delivered by nation/iify recognized ovcmighl delivery service, or by certified 
msil until nottint receipt requested service, delivered to the address for the other parly set forth 
below, or such changed uddrcss as shall hiive been provided by (he other party by a notice duly 
given hereunder: 
If to Company: The Mntru Oroup, LLC 
1 I 77 George Bush Boulevard 
Suite No. 201 
Dclray Beach, Florida 33483 
If to .Distributor: I nnerlighi, Inc. 
.867 East'2260 South 
Provo, Utah 84606 
11- Assignment of Agreement, 
'Neither this Agreement nor any rights, duties Dr obligation* hereunder may be assigned by 
Distributor without the prior written consent of Company, which may be .given or withheld in its 
sole discretion. 
12 Miscellaneous, 
'This Agreement shall bt binding upon, and inure to the benefit of, the parties hereto and 
their respective successors and assigns (provided hqwever, that nothing contained herein shall be 
construed .as .authorizing any party to assigr\ any rights or instruments which it has agreed not lo 
assign pursuant to provisions hereinabove contained). This Agreement constitutes the entire 
agreement of the parlies with respect to the subject matter hereof and may not be amended or 
modified except by a written instrument signed by each of the parties hereto, in (he event any party 
oornmenacs cxry oction or proceeding lo enforce its rights hereunder, the prevailing pasty or parties 
in any such action shall be entitled to recover all of their costs and expenses, including reasonable 
attorneys fees, incurred in connection (herewith from the non-prcvaifing party or parties, both in 
connection with the original action relating thereto and any and all appeals therefrom, No party 
shall be construed as having waived any of its rights hereunder utfless such wniver shall be in 
writing signed by the party agsinsl whom such waiver is being sought Neither the failure of any 
party to exercise ajiy power given such party hcrrundcr or lo insist upon strict compliance by any 
other party with its obligations hereunder, nor any custom or pnaciioc of ihc parlies at variance -with 
the terms hereof, shall constitute u waiver of any party's right to demand exact compliance with the 
terms hereof. This Agreement shall be construed and interpreted under (he laws of (he State of 
Florida ajid the parties agree tlmt any action or proceeding brought concerning this Agreement may 
be brought only in the courts of Polm Beach County, Florida, and each party hereto hereby consents 
to the jurisdiction oTsuch courts The parties agree that this Agreement is the result of negotiation 
by the parties, cech of whom WHS represented by counsel, and thus, this Agreement shall not be 
^ 
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construed ngainsi the. drafter (hereof. No representations, inducements, promises or ngre-mncnls, 
oral or otherwise, bclw&cn \hc parties not embodied herein or incorpornicd herein by reference shall 
be of any force or cfTccl. Thii. Agreement m«y be executed in any number of counterparts, e/Lch of 
which shall be deemed lo be an original, bui all of which, when taken together, .shall constitute but 
one ajnd the same instrument. Ail references herein to the singular shall include plural and till 
references herein to (be masculine gender ithall include Lhc feminine wd neuter genders, .and v'icv, 
versa.. 
W WITNESS THEREOF, the panics hereto have executed this instrument as of the dale 
first set forth above, 
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IJ 77 Gcort '6 Bush Blvd # J 0 l 
Dc l r ay , FL 33482 
PKCOPHO: ;• (BaflJ UB2-3ZZ7 
TSSNCJ: ' (5Q 1) 330-75S6 
Vandor ID. Wo,' &Z2 
SHTTO 
InnorLififhl inc. 
087 E 22S0 5 
PROVO, UT B4A0S 
Phone (501) Cft£-05 05 
P,0,DATE ^COUiamONCR SHIP VIA 
1Q/11/20M | kalhyChrittUanaan 
KO.B, POI^T ascouwr THKMS Y/AKEHOU** 
Nonb 
•QTY ITEU DESCRIPTION 
uwrr 
6,006 S2&J30 •520D30: D s m i s P r a l Complex •22.5OO0 
"TOTAL 
112,300,00 
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7 George Bush Blvd #101 
ray, FL 33482 
Phone No: (888) 862-3227 
Fax No: (561)330-7596 





PO NUMBER: 20978 
The POnunibormusI appear DM nil related correspondence, 
shipping papers, and invoices. 
SHIP TO 
InnerLight inc. 
867 E 2260 S 
PROVO, UT 84606 
Phone (801) 65 5-0605 









10,000 510000 510000: Skin-Deep OxyPlex 
TM 7.8500 78,500.00 
TOTAL: 78,500.00 
l. Please send two copies of your Invoice. 
I Enler this ordcrin accordance vrilh .ho prices, terms, delivery method 
and specifications listed above. 
3. Please nollfy us immediately II ya. arc unable to ship as specified. 
4. Send invoice lo: 
InnerLighllnc. 
0C7E22G0S 
Pro/o, UT M606 
Authorized ty ( Dale 
TabC 
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I Dropped 31 Pounds in 31 days! 
secuntyMF.TRics i 
-/Certified Steve Hale 853-336-8488 
Virtual Office - Login 
Click here for the Convention "Pav As You Go" Registration 
C i l '" '" ' "'" ' -*«*-«—• & I J + I 0 hup / /www innerlightinc.com/hale/beveriysassoon/index.cfrri l^ 
ggg^Y^hpoJ-c^Gmaii Google. Apple .Mac Amaibn^;Nc^s>r^ 
B E V E R L Y 
SASSQQN 
The Secret of Beautiful Skin 
mm 
pa. 
• ^ ^ j j i f a ^ , , , ' ; ^ -^  
erljrsassoorr f 'dur^en>tp^ 
Beverly Sassobri " Beverly Sassoon 
Healthy skin is essential to one's appearance. It 
marks vitality, and allows a person to exude health 
and energy. We searched through scores of 
skincare options to create a skin restoration and 
health program that could mimic what today's most 
highly trained dermatologists and plastic surgeons 
offer their patients - without our customers ever 
having to set foot in a doctor's office. 
DermaPiexTherapie is a program backed by 
science and created by doctors - and proven to 
work. It offers the synergy of the Rendon Rx 
Therapeutic Skincare line, a dermatologist-created 
exfoliating peel and skin maintenance system, and 
the miracle of OxyPlex. a product used by 
dermatologists and plastic surgeons worldwide to 
speed skin restoration and enhance cosmetic 
procedure results. 
The six-week peel will help to revitalize worn, aged 
and damaged skin; OxyPlex will rebuild cells by 
delivering much-needed nutrients and oxygen and 
reversing skin damage: and the maintenance 
cleanser and creams will help keep skin looking 
radiant and youthful. 
The DermaPlex Therapie system is the only kit in the world that marries these two powerful skincare 
products- and only doctors offered these individual programs in the past. Now they are available to you 
in a comprehensive system that will not disrupt your life, but will restore your skin to its healthiest state. 
Skin Deep OxyPlex* DermaPeel Complex* Day Creme with SPF2D 
24-7 pHvdration Creme * pHaze i Cleanser* Rendon Complex 
m 
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BEVERLY 
The Secret of Beautiful Skin 
mm 





O x y g e n Treatment • O x y g e n a n d Free 
Radica ls ' A b o u t OxyPlex 
Skin Deep OxyPlex with Pure Oxygen Clinically 
proven, scientifically designed OxyPlex is a multi-
nutrient oxygen treatment that is nothing short of 
revolutionary. Recent studies published in the Journal 
of Physiology reveal that the epidermis and dermis 
receive oxygen from atmospheric air. which means 
that the skin actually breathes. However, as our skin 
ages : it loses its ability to retain adequate levels of 
oxygen. By age 30. the ability for ceils to retain oxygen 
decreases by almost 30 and by age 50. it decreases 
by over 50 As the skin?s oxygen supply diminishes, 
lines, wrinkles and dull or lifeless skin becomes more 
pronounced. When we oxygenate our skin, we allow it 
to breathe. The benefits of oxygen in promoting wound 
repair and cellular renewal are well-documented. By 
infusing pure oxygen into the skin, we can improve its 
health and encourage the cells to purify, clarify, and 
eliminate waste and toxins more quickly. 
What are the benefits of pure oxygen for your skin? 
• Glowing Complexion 
• Cellular Repair 
• Collagen.Stimulation 
• Destruction of Bacteria 
Reduced nutrition to the epidermis from aging is one factor that causes cellular exhaustion and 
weakness. Without proper nutrition to the epidermis, cellular metabolism of the epidermal cell is 
slowed. Furthermore, the transportation of certain unwanted byproducts of cellular metabolism, such as! 
free radicals are reduced. This is an exceptional product benefit, as the accumulation of free radicals jT ' 
within the cell can lead to undesirable mutational damages in the cell and. ultimately, cancer. CxyPlex 
is one of the few products in the world that has unlocked the secret of a successful oxygen deliver/ 
system, using pure oxygen. 
Qinn n ^ n HYVPIPY • rwmaPAe! Comolex • Dav Creme with SPF 20_ 
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WHEN Y O U LOOK G O O D , 
W E LOOK GOOD, 
s k i n d e e p 
OxyPiex™ 
with Amino-/Jit.w<io 
an evo lu t ion In c e l l u l a r r e b i r t h 
Board certified plastic surgeon 
Michael F. McGuire, M.D,, F.A.C.S., 
has seen, firsthand, the skin 









Dr, McGuire, an associate clinical 
professor in the Department of 
Plastic Surgery at UCLA and chief 
• of plastic surgery at St, John's 
Hospital in Santa Monica, Calif,, 
• has been using OxyPiex™ in 
conjunction with peels and other 
cosmetic procedures for years. 
OxyPiex-1- is essential for 
cellular rebirth. 
It is clinically proven to work at 
: the cellular level to help patients' 
skin heal at a significantly faster 
rate dfter derma peels and other 
cosmetic procedures, 
The combination of the OxyPiex'" 
with the Rendon Rx Complex® 
makes the BEVERLY SASSOON 
DermaPlex Therapie™ System 
a truly revolutionary at-home 
skincare product. 
Let the power of OxyPiex'" 




OXYPLEX™ -CLINICALLY TESTED FOR SAFETY AND EFFECTIVENESS AT A MAJOR AMERICAN UNIVERSITY. 
AND USED BY PLASTIC SURGEONS AND DERMATOLOGISTS WORLDWIDE WITH ASTOUNDING RESULTS. 
OXYPLEX™ MULTI-NUTRIENT OXYGEN TREATMENT RESTORES WHAT TIME TAKES AWAY. OXYPLEX'" 
^ . . ^ ^ C C D C rTRPAi/TJFUL. HEALTHY & YOUTHFUL. 
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I l lBII i f l l l l l -iHHssiasiittiiiiik 









i$i? BS K ift SK RK leg s« »sj liffcfetet. S s > 
1HI1 i l i l p I IM lS f i l l l 11' 
iiiiasaiiiii ^  
WilSlltellKskin deep J-.-' 










I I S 
mm 
f j 
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Hi 
skin deep O x y P l e x m 
with Amino-Plex® 
the most advanced 
topical treatment available 
without a prescription 
Plastic surgeons, dermatologists and other medical specialists have used 
OxyPIex'"'1 for more than a decade to accelerate healing after cosmetic 
procedures and to treat dif f icult-to-heal wounds. 
In clinical studies (IRB approval) at a leading university, UCLA, OxyPlex m 
has been shown to reduce irr i tat ion and improve healing faster with better 
results after the follov/ing procedures; 
Laser Hair Remova l - loss irritation 
Chemical Peels - Faster healing, better result 
Laser Resurfacing - helps reduces recovery time, improves results 
Medical M i c r o d e r m a b r a s i o n - helps reduce irritation, improves resales 
Hair T ransp lan ta t ion - helps reduce irritation, improves sur\<ival rate 
Rosacea - reduces redness, reduces irritation, improves skin quality 
,-.:*._ 1*-'"^ mrhim crarrinn. nromotes healing 
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InnerLight Inc* 
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m InnerLight Inc. Phone: §01-655-0605 
867 E 2260 S 
Provo, UT 84606 
ZIQNS FIRST NATIONAL BANK 
AMERICAN FORK OFFICE 
609 E STATE RD AMERICAN FORK UT 34003 






m>imsv NATURAL BRONZE 
RATABLE IN US FUNDS 
Four Thousand Seven Hundred Ninety-Four and 51/100*******************^^^
 D n i 
GULF STREAM BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD. 
DELRAY BEACH, FL 33483 
/ / 
J^fOW-j L.-&-*z«^Z-J^ 
; ^ ^ ^ C g v 
CMO: INVOICE#1505 
H " 0 0 0 & 5 U & » H i : iE i fDDDD5l . i : Df l ^ D0L,Ea ?«• 
65084 InnerLight Inc. 
Phone: $01-655-0605 
867 E 2260 S 
Provo, U T 84606 
ZIONS FIRST NATIONAL BANK 
AMERICAN FORK OFFICE 








**mfi$L5Q NATURAL BRONZE 
PAYABLE IN US FUNDS 
Ninety Thousarld Six Hundred Fifty-Two and 5Q/100****************************K *+****+*********»i«****************'i«********* 
GULF STREAM BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD. 
DELRAY BEACH, FL 33483 
E M O : INYOICE#1468 
InnerLight Inc 
Phone: §01-655-0605 
867 E 2260 S 
Provo, UT 84606 
ZIONS FIRST NATIONAL BAN 
AMERICAN FORK OFFICE 





NATURAL BRONZE ^ **lGf 535,25 ' 
PAYABLE IN US FUNDS 
Fhousand Five Hundred Thirty-Five and 25/lOG*****^***^*^^***^*-************-*1**'**'^ **^*****-*''* ***+************#********** . 
' D o l l a r s 
GULF STREAM BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD 
DELRAY BEACH, FL 33483 
J/ 
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867 E 2260 S 
Provo, UT 84606 
ZIONS FIRST NATIONAL BANK 
AMERICAN FORK OFFICE 








)F ^ \ ^ - PAYABLE IN US FUNDS 
Twenty Thousand Five Hundred Fourteen and 30/1QO***********************^^ -D o l l a r s 
GULF STREAlyl BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD 
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InnerLight Inc. 
Phone: §01-655-0605 
867 E 2260 S 
Provo, UT 84606 
ZIONS FIRST NATIONAL BANK 
AMERICAN FORK OFFICE 









NATURAL BRONZE **23,tfi?.7$ 
PAYABLE IN US FUNDS 
Twenty-Three Thousand One Hundred Sixtv-Six and 75/100**************************************^ / D o l l a r s 
GULF STREAM BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD \ 
DELRAY BEACH, FL 33483 ^ 
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One Thousand One Hundred F i ty -F ive dnd 497] 00****** 
*W W ,*^u^„„„„„+„M ,^^+^^^^^^ 
i ^ l i ^ 
GULF STREAM BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD 
DELRAY BEACH, FL 334E3 
PAYABLE IN US HMS 
Dollars 
^ 0 ; INVOICE 1451 J^±^^^f £ 
^ ^ ^ ^ 
InnerLight Inc 
Phone; !oi~655~Q605 
867 E 2260 S 
Provo, U T 84606 
ZIONS FIRST NATIONAL BANK 
AMERICAN FORK OFFICE 








N A T U R A L B R O N Z E 
Three Thousand Eight Hundred Eighty-Four and 00 /100****** 
: M * * * * * * * * * * * * * * * * * * * * * + * * * * * * * < 
PAYABLE IN US FUNDS 
Dollars 
GULF S T R E A M B U I L D I N G 
2nd FLOOR, Suite'201 
, 1177 GEORGE B U S H B L V D 
DELRAY B E A C H , FL 3 3 4 8 3 
SMO; M C B * ^ ^ 





867 E 2260 S 
Provo, U T 84606 
ZIOUS FIRST MATI ONAL BANK 
AMERICAN FORK 0FFJCE 









N A T U R A L B R O N Z E *%0*?89 
T w o Thousand Fifty-Seven and Q0/1QO************************************* 
GULF S T R E A M B U I L D I N G 
2nd FLOOR, Suite 201 
1177 GEORGE B U S H B L V D 
DELRAY B E ^ C H , FL 3 3 4 8 3 
PAYABLE IN US FUNDS 
* * * * * * * * * * * * * * * * 3 * J ( Dollars 
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ER« NATURAL BRONZE * **3>548 n 
liree Thousand Five Hundred Forty-Eight and 30/100*^**^******************+^+*+*+^***/ i 
PAYABLE IN US FUNDS 
***** + *********-£***********=» 
/ / / Dollars 
GULF STREAM BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD 
DELRAY BEACH, FL 33483 
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PAYABLE IN US FUNDS 
Seventy-Eight Thousand Five Hundred and 00/100***************************^^ / / J Jf / DO A. A. cLJC S 
GULF STREAM BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD 
DELRAY BEACH, FL 33483 
T. 
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NATURAL BRONZE **354785>9Q 
Thirty-Five Thousand Seven Hundred Eighty Five and 90/100***********************4 
PAYABLE IN US FUNDS 
( < * * * * * * * * * * * * * * * * * * * * * * * 
Dollars 
GULF STREAM BUILDING 
2nd FLOOR, Suite 201 
1177 GEORGE BUSH BLVD 
DELRAY B^ACH, FL 33483 
EMO: INVOICED 1 447 
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T O : NATURAL BRONZE 
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Page I of 1 
s rus&o 
From: "America West Airlines" <hpagentlink.reservations@americawest.com> 
To: <suerusso@belisouth.net> 
Sent; Wednesday, September 29, 2004 12:14 PM 











Conf i rma t ion ~ UEGFGL 
Thank you for flying America West. Your purchase is now complete and your reservation has 
been electronically ticketed. No paper tickets will be sent. 
Confirmation 
Date-issued 






09/29/04 at 09:10 AM 
American Express •*•*•"-** 
3326.70 
BEVERLY SASSQON 




Party of \ Frequent Flyer # Ticket # 




Passenger Special Needs 
JD&p3rt 
111:45 AM 
Fri. Oct 15 
12:03 PM 
Sun, Oct 17 




Los AngoJcs, CA 
Boeing 737-300 
Las Vegas, NV 
Airbus A320 
To 
Lqs Vegas, NV 
Los Angeles, CA 
Arrive 
12:44 PM 
Frt. Oct 15 
01:20 PM 





Class: First | 
1 Pas3enger(s) 
Fare 





T e r m s and Condi t ions 
Tickel is non-lransteroblc 
Tickel expires one year horn date o/ issue 
Tills ticks', is non-refundable. Any change to this reservation {including (light, dales, or cities) is 
subjec' to a $100 change fee per passenger. The new itinerary/ will be pnced Bt the lowest 
oveitoble published (ore at [he lime of change, which may result in a fare increase. 
Travef is valid en AmeriCD West or America West Express only 
9/29/2004 
uMit? r.m nil n,*-<r"?K c\c\ t\ n n w 
R i w r s C a t i n e l l a 5 6 1 . 8 0 1 6 
1 0 / 2 J / 2 0 0 4 1(1:04 FAX 702G327273 JBANfJAUSr KAY A / R S ) D 0 2 
Rworvationa 
TTV 877*432-710 J 
.•». •.*•••' v to. (' C y 
MANDALAY BAY 
39SO Las Vagus Blvd. South /Las Vagust Ncwda 89119 
tiamc BEVERLY SA5SOQN 
Addrtu 
Rxto 
lUom MB 2 4 1 2 2 
Arrive 1 0 / 1 5 / 0 4 





FAX I -703.632.7£W 
Corapaoy N'aiuc **SABRE*-* 
Group Code PPLEQDS 
Trove* Agwf No. Page 1 
Recv No 3S249iG5i:jl2 
ThanJt you for staying with us 
DATE REFERENCE DESCRIPTION 
10/15/04 382749002144 ROOM CHARGE MB24122 
TAX 
10/15/04 382745150.948 APPLIED DEPOSIT 
JOOXXX3CXXXXXX4 o Q 5 
10/15/04 382745156073 ROOM SERVICE 
20/16/04 382759002234 ROOtf CHARGE MB24122 
TAX 
10/16/04 382755205532 ROOT SERVICE 
1O/1B/04 3G2755241376 IN ROOM BOTTLED WATER 
10/17/04 3B2765295277 ROOM SERVICE 












3 8 1 , 
.00 
.01 







5 3 ^ 
BALANCE 
TWAK'K T?OW FG-'R STAYfWG AT IWaM»ALftV SAY 
,00 
J»gr*al»>K. rrrwj^jkJJyDiililt.Wlbc loVJrtJrnJ |«TTOU, AIM. *r j«q»*n»lJrj» fall Is p%p p«y «>rik<cl>q>Gi: HultoO, H> k*vr jOUbffl »«/*ic»t*ic4 
m<K<<»rJ J*«it»»t*»Tf»U Wj«i|* lo diM-^ JttftuI tm «lntV-*ML Tic U*tuiti*y CUy IUaorlA O i l no asniittts »> mpwu4b»*r Rx 
r«t*>cy or-vnWI<Vu oMcWjh^Wai to r»raiMydrpnjolbo>a, wWck nrrpr»>lijf« nhxmt rAit-pciM Ibt tjAno ftp, 
MANDALAY SAY 





Depar tu re U«tc 
R « . NO. 





S igna tu re 5l£«aiur t 
v\uu(xiLYvnw<s{(zmi. nxrovsoroxDefAirrunc VAUDONLYWllX*MlCXKl>. HJtflXrS UfOrt SO-ARI URC 
R i c K C a t i n e l l a 56 1 & 
a a i G 
Natural Bronze-Matrix 
1177 George Bush Blvd. 
Suite #201 
DcLray Beach, FL 33483 
Invoice 
nr. ! « n"'-' 
TabF 
Matrix Groitp LLC 
1355 V/est Palmetlo Park Road 
Suite #348 
Boca Raton, FL 33486 
| D ^ 
\ i/2/72005 





867 h 2260 S 
Pruvo, UT W606 
P.O No. Terms 




Beverly Sassoan Appezmncc Fec-Pcr Contract 
Newark, New Jersey March llfhand i2tti, 2005 
2.500.00 2.500 U0 
Total 52,500.00 
Payment History 10/25/2006 
Customer:J... (nncrLighl Inc 
Date Race;.., 04/04/2005 Payment M... 




jnyotces Paid, Statement Charges Paid and Payment Deposit 
Type Date /^ fjumber Amount 
invoice 03/21/200 *2,500 00 
TabG 
)) ] 4 OG 0 7 : 3 9 a J a f f 
New.s&EvcnU, ; 
News Releases 1 Events & Trade shows 
Press Releases 
Contact: 
David K. Waldman/John W. Heiishorn The Ouigley Corporation 
Lippert Heiishorn & Associates Carl Fonash 
(212) 838-3777 Shareholder Relations 
dwaldrnan@lhai.com (267) 880-1111 
The Quigley Corporation Announces Launch of BEVERLY SASSOOhl 
Product Line by Its InnerLight Subsidiary 
DOYLESTOWN, PA. - November 3,.2004 • The Quigley Corporation (Nasdaq: 
QGLY) today announced that InnerLight, Inc., a wholly-owned subsidiary within the 
company's Health and Wellness Segment, has secured Beverly Sassoon as a 
spokesperson and launched an exclusive skin care line under the BEVERLY 
SASSOON brand name. 
The BEVERLY SASSOON skin care line has been created and endorsed by Marta 
Rendon, M.D., President-Elect of the American Academy of Dermatology as well as 
Michael F. McGuire, M.D., F.A.C.S., a board certified faculty member at the UCLA 
Medical Center in Los Angeles, 
Stephanie McAnaly, President of InnerLight, said, "Beverly Sassoon's decades of 
experience in beauty care products, as well as her celebrity status, are a perfect fit for 
ihese revolutionary tested skin-care products. InnerLight is thrilled to market the 
BEVERLY SASSOON skin care brand." 
The BEVERLY SASSOON exclusive skin care products are ail tested by the Doctors 
who developed them. The line of products is available in (he BEVERLY SASSOON 
Dermaplex Therapie Kll. The Kit includes the DermaPeel complex facial peel system, 
as well as OxyPlex, a soothing agent shown in testing to reduce the recovery time 
from skin treatments. Together, these doctor-developed cosmeceuticals provide a 
safe, at home, skin-care system that can provide the same results as costly 
treatments. Also available in the kil is the BEVERLY SASSOON Day Creme and 24-7 
pHydration Night Cream, with patented Rendon Rx Complex. Each ol the BEVERLY 
SASSOON products available in the kit can also be purchased separately. 
The Quigley Corporation (Nasdaq: QGLY, htlp.7/www.Quigleyco.com) is a leading 
developer and marketer of diversified health products including {he COLD-EEZE® 
family ol patented zinc gluconate glycine (ZIGG™) lozenges and sugar free tablets. In 
September of 2004, The Company has also formed a wholly owned subsidiary, 
Quigley Manufacturing, Inc with the acquisition of two FDA approved facilities to 
manufacture its COLD- EEZE® branded lozenges InnerLight. Inc., a wholly owned 
subsidiary, was formed in January 2001 for the purpose of introducing new products tc 
-i^hir-,r.e through a network of maepentienl distributors In addition to 
^~ ^omnanv has formed Ouigley Pharma inc. 
Jitt|j://w teyc;o.corc)/nowi,7niM < w , 
J l 14 QG 0 7 : 2 ) a J a f f - 3 z> n n c . 
News & Events : ht!p://w» , deyco.com/news/nr/1 10304.{Jlip 
(http://www QuigleyPharma.com), a wholly owned ethical pharmaceutical subsidiary, 
to introduce a line of naturally derived palented prescription drugs The Quigley 
Corporation's cuslomers include leading national wholesalers and distributors, as well 
as independent and chain food, drug and mass merchandise stores and pharmacies. 
Certain statements in this press release are "forward-looking statements" within the 
meaning of the Private Securities Litigation Reform Ac! of 1995 and involve known and 
unknown risk, uncertainties and othef factors that may cause the company's actual 
performance or achievements to be materially different from the results, performance 
or achievements expressed o\ implied by the forward-looking statement. Factors that 
impaci such forward-looking statements include, among others, changes in worldwide 
general economic conditions, changes in interest rates, government regulations, and 
worldwide competition. 
Home | About Us ) Investor Relations | Business Units | News & Events | Contact Us 

















Putting the Care in Health 
Phone: (215)345-0919 
Fax: (215)345-5920 
www quiqleyco com 
Unique and Diversified Healthcare Opportunity 
Snapshot February 25,2005 
The Quigley Corporation develops and markets diversified healthcare products. For nearly a decade, 
the Company has been developing, manufacturing, and marketing its proprietary Cold-Eeze® family 
of patented zinc gluconate glycine (ZIGG™) cold-remedy lozenge products. It has also developed a 
variety of product extensions, which include Cold-Eeze Sugar Free Tablets, Cold-Eeze® Lozenge 
Honey Lemon Flavor, Cold-Eeze® Green Tea with Honey, Cold-Eeze® Bubble Gum, and Cold-
Eeze Spearmint Gum. The Company has also launched Kidz-Eeze™ Sore Throat Pops. In January 
of 2001, the Company established an ethical pharmaceutical segment, Quigley Pharma, to diversify 
by gaining entry into the prescription drug market, and ensure safe and effective distribution of any 
potential new products. Quigley Pharma addresses medical conditions that may be overlooked by 
large capitalization pharmaceutical companies. Prior to the creation o f Quigley Pharma, the 
Company founded Darius International Inc., which specializes in introducing proprietary products 
(specifically health and wellness products) into the marketplace through a network of independent 
representatives. 
Recent Financial Data 
Ticker (Exchange) QGLY (NASDAQ) QUIGLEY CORP 
as of 23-Feb-2005 
Recent Price (02/25/05) 
52-Week Range 
Shares Outstanding 
Market Cap. (mm) 
Average 3-month vol. 
Insider+5% Owners 
Institutional Owners 
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Copyright 2WW Yahoo I Inc. http;//f1 nance.yahoo.com/ 
The Quigley Corporation's Cold-Eeze product is the only such cold product available with the patented 
ZIGG™ formulation, clinically proven effective in two studies for reducing the duration and severity of 
common cold symptoms by 42%. Cold-Eeze® has national distribution throughout the U.S. in well-
known drug and mass merchandise stores and pharmacies such as Wal-Mart, Target, Walgreens, CVS 
Corp., Sam's Club, and Costco, among others. 
Quigley Pharma is developing a diversified pipeline of compounds including but not limited to (1) QR-
333 for diabetic peripheral neuropathy, for which the compound is undergoing a series of toxicity 
studies to support the safety of this naturally-derived compound prior to beginning a human Phase UB 
dose ranging study; (2) QR-336 for systemic radiation, for which encouraging results were seen in a 
preliminary non-Good Laboratory Practices (GLP) animal study of this naturally-derived radio protective 
compound against ionizing radiation; (3) QR-435 for influenza, which has demonstrated efficacy in 
significantly reducing the severity of illness in ferrets infected with the influenza A virus; and (4) QR-440, 
a naturally-derived compound developed to treat arthritis and related inflammatory disorders. 
For QR-435, Quigley Pharma is considering initiation of a Phase II Proof of Concept human clinical trial 
in Europe, or in Israel, and may undertake further animal model studies to determine if the formulation is 
•• . .- r_ u^ s
 + r Q Q i m o n f n f p H r j i t i n n a j incjicati0ns, including severe acute respiratory syndrome 
PimuiK ttie Cate in tlealih 
02/24/2005—The Quigley Corporation reported net sales of $17.8 million, an increase of 8.3%, for the 
fourth quarter ended December 31, 2004, compared to $16.4 million reported for the same period in 
2003. For the year ended December 31, 2004, net sales were $43.9 million, an increase of 5.9%, 
compared to $41.5 million in 2003. 
01/24/2005—Announced a research and development update for its wholly-owned Quigley Pharma 
(Ethical Pharmaceuticals) subsidiary, which is developing natural-source prescription medicinals for 
Influenza A, radiation dermatitis, and diabetic neuropathy. 
12/20/2004—Announced that Doctors Mark Lebwohl and Phillip A. Low have been appointed to the 
scientific advisory board of Quigley Pharma, Inc. 
11/05/2004—In response to news reports citing a lawsuit filed in Bucks County, PA, by eight consumers 
who are taking legal action against The Quigley Corporation, company officials said they had no 
knowledge of the lawsuit until a faxed complaint was received at 2:15 PM EST on November 5, 2004. The 
Company has yet to be officially served, and upon a cursory look at the faxed documents, the company 
considers the suit to be frivolous and without merit, and will defend it vigorously. The company reaffirmed 
the safety of its Nasal Spray due to completion of clinical safety studies conducted prior to retail 
introduction in September of 2003. 
11/03/2004—Announced that InnerLight, Inc., a wholly-owned subsidiary within the company's Health and 
Wellness Segment, had secured Beverly Sassoon as a spokesperson and launched an exclusive skin 
care line under the BEVERLY SASSOON brand name. 
10/28/2004—Reported third quarter financial results. Net sales for the third quarter of 2004 were $9.7 
million compared to $9.9 million reported for the same period in 2003. For the nine-months ended 
September 30, 2004, net sales were $26.2 million, compared to $25.1 million in 2003. 
10/13/2004—An 8-K filed with the SEC on September 13, 2004 stated that The Quigley Corporation 
notified its customers of its decision to discontinue the Cold-Eeze® Cold Remedy Nasal Spray product 
within its line of cold remedy products. The decision was made because the product has not developed 
into a viable entry in the nasal spray cold remedy category. Since its launch approximately one year ago, 
the product has not met either the Company's sales expectations or its return on investment projections. 
Based on the Company's preliminary estimates, the discontinuation of the nasal spray product will result 
in an approximately $422,000 write-off of inventory and an approximately $974,000 charge to net sales 
resulting from anticipated customer returns of the product. As a result of all charges, the Company's 
results for the third quarter will be adversely impacted by approximately $1,361,000. At this time, the 
Company does not anticipate any additional future charges. 
10/12/2004—Announced that the U.S. Patent and Trademark Office has approved the issuance of a 
patent for the company's QR-440, filed on April 23, 2003, for a naturally-derived compound developed for 
the treatment of arthritis and related inflammatory disorders. The company is preparing to begin 
preclinical testing, leading to a submission of an Investigational New Drug application to the U.S. FDA for 
potential approval as a prescription drug. 
10/05/2004—Announced the completion of the asset purchase with JOEL, Inc., as announced on August 
20, 2004, for approximately $5.1 million, which includes $4.1 million in cash and $1.0 million of the 
Company's stock. The transfer of assets includes inventory, as well as land, buildings, machinery and 
equipment of two manufacturing facilities, located in Lebanon and Elizabethtown, Pennsylvania. JOEL, 
Inc. has been the exclusive manufacturer of the Company's Cold-Eeze® Lozenge since its launch in 1995. 
08/20/2004—Signed an asset purchase and sale agreement with JOEL, Inc. for $5.1 million, which 
includes $4.1 million in cash and $1,0 million of the Company's stock. 
R" T a t i n e J i a 
PRNewswire 
Home Send Rakus* TOCIA/E N«WS Multimedia . Industry & MarK«ts frtuirnHttonaJ inuostor N»WS RSS Our S«rvio#s About Us ConUct Us 
Industry News 
Quigley Increases Revenues for the Fourth Quarter and Fiscal Year 
- Profitability Continues in 2004 while Investing $3.2 Million in R&D -
DOYLESTOWN, Pa., Feb. 24 /PRNewswire-FirstCall/ — The Quigley Corporation 
(Nasdaq: QGLY) today reported net sales of $17.8 million, an increase of 8.3%, 
for the fourth quarter ended December 31, 2004, compared to $16.4 million 
reported for the same period in 2003. For the year ended December 31, 2004, 
net sales were $43.9 million, an increase of 5.9%, compared to $41.5 million 
in 2003. 
Net sales of the Company's Cold Remedy segment increased 10.1% for the 
fourth quarter of 2004 as compared to 2003. Net sales of the Health and 
Wellness segment decreased 9.4% during the quarter, due to a decline in the 
number of active domestic independent representatives, which was partially 
offset by an increase of 14.1% in this segment's European sales as compared to 
2003. 
The increase in net sales for the year ended December 31, 2 004 reflects an 
11.5% increase in the Company's Cold Remedy segment and also reflects a 3,2% 
decrease in net sales for the Health and Wellness segment, which were offset 
by this segment's gains in international distribution of 135.4%. Even though 
the incidence of colds during 2004 were fewer than the previous year, the 
Company's Cold Remedy net sales increase for the year ended December 31, 2 004 
reflects the success of expanded targeted advertising, marketing initiatives 
and new product extensions of COLD-EEZE(R), which have generated greater 
consumer awareness and purchasing of our products. 
Net income for the fourth quarter ended December 31, 2004 was $2.0 
million, or $0.13 per share, compared to net income of $2.5 million, or $0.17 
per share, for the same period last year. Net income for the year ended 
December 31, 2004 was $453,000, or $0.03 per share, compared to a net income 
of $675,000, or $0.05 per share, for the same period last year • During the 
fourth quarter and year ended December 31, 2004, the Company incurred research 
and development costs of $837,000 and $3.2 million, respectively, as compared 
to $766,000 and $3,4 million, for the comparable periods of 2003. 
Additionally, net income margins by segments for the year 2004 are relatively 
consistent with net income margins attained in 2003. 
Gross profit margins for the quarter and year ended December 31, 2004 
remained relatively unchanged as compared with the same periods last year. Net 
income for the fourth quarter and year ended December 31, 2004 were primarily 
driven by profit gains from fhe increased sales, which were offset by an 
increase of $1.0 million in advertising costs. The fiscal year results were 
also affected by a $178,000 increase in other income, which was offset by a 
charge to gross profit margins of $1.4 million, or $0.09 per share, related to 
the discontinuation of the Company's COLD-EEZE(R) Cold Remedy Nasal Spray 
product. This charge includes a $672,000 write-off of nasal spray inventory 
and a $680,000 reduction to net sales resulting from anticipated customer 
returns of the product. 
No tax or tax benefits to reduce income or losses are provided for the 
quarters and year ended December 31, 2004 and 2003, since the Company is in a 
net operating loss carry-forward position, which is from the cumulative effect 
R "atinella OOJ , ^^^_ 
of deducbions attributed to options, warrants and unrestricted stock from 
previous years' taxable income. 
On October 1, 2004, the Company acquired the assets of JoEL, Inc., 
encompassing inventory, land, buildings, machinery and equipment of two 
manufacturing facilities, located in Lebanon and Elizabethtown, Pennsylvania 
for approximately $5.1 million. The facilities are FDA approved and 'have been 
the exclusive manufacturing sites of the Company's COLD-EEZE(R) lozenge since 
its launch in 1995- The purchase of the manufacturing facilities allowed for 
the establishment of Quigley Manufacturing Inc • , which protects the 
proprietary manufacturing process of COLD-EEZE(R) and is anticipated to 
improve cost efficiencies as volume production increases and allow for the 
manufacture of other brands. 
Guy J, Quigley, Chairman, President and Chief Executive Officer stated, 
"We are pleased with our results for 2004 which reflect increased sales of our 
core products and greater market penetration of our COLD-EEZE(R) Cold Remedy 
products which enabled us to further fund pharmaceutical research and 
development. In addition to increasing annual revenue, gross margins for the 
year would have increased without the previously mentioned $1.4 million 
one-time costs associated with a product discontinuation. 
"We expect that our recently introduced new or improved products including 
COLD-EEZE(R) Bubble Gum and COLD-EEZE(R) 'Green-Tea with honey' lozenges will 
garner greater consumer acceptance and enhance product sales. We will continue 
to develop products that appeal to adults as well as a younger demographic, 
which could represent a significant opportunity for expansion in market v-^____ 
penetration and future growth. 
~~ "The main core of our Health and Wellness Company, our Supergreens (TM) 
line of products developed by Dr, Robert 0. and Shelley Redford Young, 
continues to move forward with loyal distributors. The Company is also excited 
by the launch of an exclusive skin care line under the BEVKR'LTT SASSOON"brand 
name to diversify trfris" segment's product offerings. 
"We also remain focused on expanding our wholly-owned Ethical i_ _ 
Pharmaceuticals subsidiary, Quigley Pharma, which is developing natural-source 
prescription medicinals for Diabetic Neuropathy, Systemic Radiation, Influenza 
A, and Rheumatoid Arthritis. We continue moving forward with our development 
and testing phases of ethical pharmaceutical drugs and are confident that this 
segment of our business will be a source of future growth for the Company," 
concluded Mr. Quigley. 
The following is a list of formulations currently in the Quigley Pharm 
pipeline and an update on their progress: 
Diabetic Neuropathy -- QR 333: Per the FDA's instructions at the last 
Pre-IND Meeting for the continued development of this drug; the compound is 
undergoing a series of toxicity studies to support the safety of this 
naturally derived compound for the relief of symptoms of diabetic peripheral 
neuropathy, prior to beginning a human Phase IIB dose ranging study. The 
company expects the toxicity studies to be completed by June 2 0 05. The 
company hopes to begin pivotal studies on this compound in 20 05. 
Systemic Radiation — QR336: There were encouraging results seen in a 
preliminary non-GLP animal study of this naturally derived radio protective 
compound against ionizing radiation; A pre-IND meeting was held at the FDA in 
October of 2004 with the Division of Medical Imaging and Radiopharmaceutical 
Drug Products. A GLP controlled animal study of the QR 336 formulation for the 
Radioprotection/Treatment of Radiation Lethality Induced by Four MeV Photons 
in the C3H Mouse will begin this year after a short series of experiments to 
further define the compound's method of action. 
Influenza A — QR435: Retroscreen LTD. at The University of London has 
started a final animal model influenza study in preparation for a proposed 
human Proof Of Concept Study to start in mid-2005. The study "Prophylactic 
-^•hon-Mal of different QR-435 antiviral nasal spray formulations in the 
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David L Arnngton (4267; 
Matthew (\. Grinimei (9692; 
DURHAM. .IONICS & PINI-,GAK 
I 11 East Broadway. Suile 900 
Post Office Box 4050 
Sail LakeCily. Utah 84 110-4050 
Telephone. (KOI; A 15-3000 
Thomas J'.J. MacAniff 
PA Attorney J.D. No. 01895 
Ursula J-J. Leo 
PA Attorney i.D No. 91281 
EASTBURN AND GRAY. P.C. 
60 East Court Street 
Doyleslown. PA 18901 
Telephone (215; 345-7000 
Attorneys foi Plaintiff lnnerhght, Inc. 
Fourth Judicial District Court 
of Uteh County, State ©f uta'n 
^iAl^J!^ 
.Deputy 
IN THE FOURTH JUDICIAL DISTRICT COURT 




THE MATRIX GROUP. LLC 
Defendant. 
ORDER (1) GRANTING 
PLAINTIFF'S MOTION TO STRIKE 
PORTIONS OF THE THIRD 
AFFIDAVIT OF ANTHONY R. 
CANTINELLA 
AND 
(2) DENYING DEFENDANT'S 
MOTION TO STRIKE PORTIONS OF 
TATE'S AFFIDAVIT 
CiviJ No. 060400775 
.1 ud<ie Fred D Howard 
Defendant The Matrix Group. LLC ("Matrix";, hied iLs Motion lo Strike Portions of 
Tate's Affidavit. Plainliff. inncrlighl. inc. ("lnnerhght"; moved to strike paragraphs 3. 6-14 and 
Exhibits A & B of the Third Affidavit of Anthony R CantinelJa. Matrix filed this affidavit after 
^ ^ r 
Innerhghfs bnefrng had closed along with Matrix's reply memorandum in support of Matrix's 
motion foi summary judgment These motions came on foi on January 17. 2007. in conjunction 
vvilh the parties' cross motions loi summary judgment. David L Arlington and Matthew G. 
Gnmmei appeared loi Plaintiff. Jnneiiight Jnc Stephen Quesenberry and CharJes L Persehon 
appeared ioi Defendant. Matrix. The parties agreed to submit both motions 
Having studied the motions, authorities and affidavits, the Court ORDERS AS 
FOLLOWS: 
L Plaintiff Jnnerlight lnc.\s Motion to Strike Portions of the Third Affidavit of 
Anthony R. Canlinella, which was unopposed, is GRANTED. 
2. Defendant The Matrix Group. LLC's Motion to Strike Portions of Tate's 
Affidavit is DENIED. 
Dated / ^ g ^ f # • 2007. 
APPROVED AS TO FORM 
BY THE COURT ^L^JL^O 
Stephen Quesenberry 
Charles L. Perschon 
Attorneys for The Matn> Group, LLC1 
— — • " > . 
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Case No: 060400775 CN 
Judge: FRED D HOWARD 
Date: November 2 8,2006 
ORAL ARGUMENT is scheduled. 
Date: 01/17/2007 
Time: 10:30 a.m. 
Location: Second Floor, Rm 202 
FOURTH DISTRICT COURT 
125 N 100 W 
PROVO, UT 84601 
Before Judge: FRED D HOWARD 
The Court has set aside 90 minutes to hear oral argument on the 
following motions: 
1. Innerlight's Motion for Summary Judgment 
2. Defendant's Motion for Summary Judgment 
3. Defendant's Motion to Strike Portions of Tate's Affidavit 
Dated this "2Kg day of iJweMbv.r- 2 0 &C • 
U. A. /I, a. 
District Court Deputy Clerk 
Case No: 060400775 
Date: Nov 28, 2006 
The Court will provide interpreters for criminal cases and domestic 
violence cases involving protective orders or stalking injunctions. 
(Fees in criminal cases may be imposed at the judge's discretion.) 
IF YOU NEED AN INTERPRETER IN A CRIMINAL CASE OR DOMESTIC VIOLENCE 
CASE PLEASE NOTIFY THE COURT at (801)429-1006 (five days before the 
hearing, if possible) . 
FOR ALL OTHER CASES, you must bring someone with you to 
interpret. If you do not know someone who can help you, the names 
of court interpreters you can hire are listed on the courts' 
website at http: //www. utcourts . gov/resources/interp/certif ied. htm. 
If you do not have access to the internet, ask the court clerk to 
print off a copy of this list for you. 
In compliance with the Americans with Disabilities Act, individuals 
needing special accommodations (including auxiliary communicative 
aids and services) should call TERI at (801)429-1112 at least three 
working days prior to the proceeding. (For TTY service call Utah 
Relay at 1-800-346-4128 or 711) 
Case No: 060400775 
Date: Nov 28, 2006 
CERTIFICATE OF NOTIFICATION 
I certify that a copy of the attached document was sent to the 
following people for case 060400775 by the method and on the date 
specified. 
METHOD NAME 
Mail THOMAS F J MACANIFF 
OTHER PARTY 
60 EAST COURT STREET 
DOYLESTOWN, PA 18901 
Mail DAVID L ARRINGTON 
ATTORNEY PLA 
111 E BROADWAY STE 90 0 
SALT LAKE CITY UT 84111 
Mail STEPHEN QUESENBERRY 
ATTORNEY DEF 
3319 N UNIVERSITY AVE 
PROVO UT 84604 
Dated this Z% day of /'J<WVlK-> 20 flC 
Deputy Court Clerk 
